CardiologyOnline.net

Cardiology Xagena

Xagena Mappa
Xagena Newsletter
OncologiaMedica.net
Mediexplorer.it

Results from animal models and observational studies have raised concerns regarding the potential cataractogenic effects of statin treatment. A study has investigated whether common and rare genetic ...


Gout is a common comorbidity in heart failure ( HF ) patients and is frequently associated with acute exacerbations during treatment for decompensated HF. Although Colchicine is often used to manage ...


Class 1C antiarrhythmic drugs ( AAD ) have been associated with harm in patients treated for ventricular arrhythmias with a prior myocardial infarction. Consensus guidelines have advocated that thes ...


The relationship between statin ( HMG-CoA reductase inhibitors ) treatment and Coronavirus Disease 2019 ( COVID-19 ) mortality has been discussed due to the pleiotropic effects of statins on coagulati ...


The Committee for Medicinal Products for Human Use ( CHMP ) of the European Medicines Agency ( EMA ) has granted a positive opinion for Vericiguat ( Verquvo ), a soluble guanylate cyclase ( sGC ) stim ...


Major bleeding after acute coronary syndrome predicts a poor outcome but is challenging to define. The choice of antiplatelet influences bleeding risk. Major bleeding, subsequent myocardial infarct ...


Interim results from the ongoing phase 1 study of ALN-AGT, a subcutaneous investigational RNAi therapeutic targeting liver-expressed angiotensinogen ( AGT ) for the treatment of hypertension, were ann ...


Troponin elevation is common in hospitalized COVID-19 patients, but underlying aetiologies are ill-defined. Researchers have used multi-parametric cardiovascular magnetic resonance ( CMR ) to assess ...


The effects of direct oral anticoagulants in nonvalvular atrial fibrillation should be assessed in actual conditions of use. France has near-universal healthcare coverage with a unified healthcare i ...


Mavacamten improves heart function and symptoms in patients with obstructive hypertrophic cardiomyopathy ( HCM ), according to results from the EXPLORER-HCM trial. Currently available medical treat ...


The coronavirus disease 2019 ( COVID-19 ) pandemic has resulted in severe psychological, social, and economic stress in people’s lives. It is not known whether the stress of the pandemic is associated ...



New data from a sub-analysis of the landmark phase III DAPA-HF ( Dapagliflozin And Prevention of Adverse-outcomes in Heart Failure ) trial have shown that Dapagliflozin ( Farxiga ) has reduced the inc ...


COVID-19 can have fatal consequences for people with underlying cardiovascular disease and cause cardiac injury even in patients without underlying heart conditions. Experts have known that viral i ...


Elevated apolipoprotein C-III ( apoC-III ) levels are associated with hypertriglyceridaemia and coronary heart disease. AKCEA-APOCIII-LRx is an N-acetyl galactosamine-conjugated antisense oligonucle ...